Nitazoxanide, Ivermectin, and Artemether effects against cryptosporidiosis in diabetic mice: parasitological, histopathological, and chemical studies

Bibliographic Information
Authors: El-Ashkar A.M.; Mahmoud S.; Sabry H.; Guirguis N.; El Komi W.; Ali E.; Abu Shousha T.; Abdelmksoud H.F.
Journal: Journal of Parasitic Diseases
Publisher: Springer
Publication Date: 7 September 2022
Volume / Issue: Volume 46 / Issue 4
Pages: 1070–1079
ISSN: 9717196
DOI: 10.1007/s12639-022-01527-w
Scopus: View on Scopus
Document Type: Article
Access: All Open Access; Green Open Access; Hybrid Gold Open Access
Authors and Affiliations
El-Ashkar A.M., Department of Medical Parasitology, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Mahmoud S., Department of Medical Parasitology, Theodor Bilharz Research Institute, Giza, Egypt; Sabry H., Department of Medical Parasitology, Theodor Bilharz Research Institute, Giza, Egypt; Guirguis N., Department of Medical Parasitology, Theodor Bilharz Research Institute, Giza, Egypt; El Komi W., Department of Medical Parasitology, Theodor Bilharz Research Institute, Giza, Egypt; Ali E., Department of Medical Parasitology, Theodor Bilharz Research Institute, Giza, Egypt; Abu Shousha T., Department of Pathology, Theodor Bilharz Research Institute, Giza, Egypt; Abdelmksoud H.F., Department of Medical Parasitology, Theodor Bilharz Research Institute, Giza, Egypt
Abstract
Human cryptosporidiosis is one of the most significant causes of water borne epidemics of diarrhea worldwide. It is extremely important in immunocompromised hosts and malnourished children as it could cause severe life-threatening diarrhea. Despite the global burden of the disease, there are only few available therapies against cryptosporidiosis. Diabetes mellitus is a common metabolic disorder that impair both the innate and adaptive immune responses of the patient. This study aimed to test the effect of Nitazoxanide, Ivermectin, and Artemether against cryptosporidiosis in diabetic mice. Sixty white albino mice were categorized into 6 groups; 10 mice each: GI: normal non-infected non-treated (healthy- control), GII-GVI (diabetic groups), GII: non-infected non treated (diabetic control), GIII: infected non treated (infected control), GIV: infected and treated with Nitazoxanide (NTZ), GV: infected and treated with Ivermectin (IVC), GVI: infected and treated with Artemether (ART). Parasitological, histopathological, and chemical examinations were done to evaluate the effect of NTZ, IVC, and ART against cryptosporidiosis in diabetic mice. Parasitological examination revealed maximum reduction of oocyst shedding in GVI, while histopathological examination showed the least pathologic changes in GV with mild vascular wall fibrosis and moderate lymphocytic infiltration of islets of Langerhans. Measurement of blood glucose level showed the best results with GIV. Nitazoxanide is effective against cryptosporidiosis in diabetic patients with minimal hyperglycemia, Artemether is especially effective in reducing the oocyst shedding in stool, whereas Ivermectin is associated with the least pathological changes in pancreatic islets of Langerhans. Graphical abstract: [Figure not available: see fulltext.] © 2022, Indian Society for Parasitology.
Keywords
Artemether; Cryptosporidium; Diabetes mellitus; Ivermectin; Nitazoxanide; eosin; hematoxylin; streptozocin; albino mouse; animal experiment; animal model; animal tissue; Article; blood glucose monitoring; body weight; cell infiltration; comparative study; controlled study; cryptosporidiosis; drug effect; feces analysis; fibrosis; histopathology; hyperglycemia; lymphocytic infiltration; male; mouse; nonhuman; pancreas islet; parasitology
Citation Information
Scopus Citations: 8
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
